Dipna Pharmachem has informed that Dipna Pharmachem has received Sales order of Rs 12.75 Crores from the Fact trading Co., Morbi to deliver Melamine powder and marks a significant step forward in our business growth. The details required under Regulation 30 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 09/09/2015 is enclosed as Anexure-1.
The above information is a part of company’s filings submitted to BSE.
